Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform; as well as operates hospitals. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.

Sector

Consumer Cyclical

Industry

Drug Manufacturers - General

CEO

Xie, Fangmin

Employees

485

Website

Jianke.com

IPO Date

2024-07-09

Headquarters

Building S, Kehui Jingu, Floor 1-2, 4th Street, No. 99, Science Avenue, Luogang Science City, Huangpu District, Guangzhou, Guangdong Province China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Fangzhou 6086

Fangzhou Earnings Call Summary

Fangzhou Earnings

Transcripts

Events

About Fangzhou Inc.

Fangzhou
6086